Kegonsa Seed Fund

Semba Biosciences

Founders: Anil Oroskar, Kegonsa Seed Fund
Inventor: Anil Oroskar
Manager: Robert Mierendorf (CEO)
Industry: Biotechnology Equipment and Devices
Established: 2005
Headquarters: Madison, Wisconsin

Semba Biosciences, Inc. is a biotechnology company that markets the Octave Chromatography System™, a highly scalable, cost-effective, desktop-deployable simulated moving bed chromatography (SMBC) system.

Semba Biosciences also sells related consumables to both Octave customers and third parties.

Investment History:
  • Seed funding was provided by Anil Oraskar and the Kegonsa Seed Fund, the company founders, as well as current management.
  • The Kegonsa Coinvest Fund led the first round financing.
  • The Kegonsa Coinvest Fund led the second round financing.

Company Leaders

Anil Oroskar, Ph.D., invented the technology behind Semba Biosciences, Inc. and is the company's co-founder.

Anil also co-founded Orochem Technologies, which serves the biotechnology, forensics, pharmacokinetics, and drug discovery industries. He also served previously served as UOP's manager of Separation Processes.

Anil has a Ph.D. in chemical engineering from the University of Wisconsin-Madison.

Robert Mierendorf, Ph.D., is the President and CEO of Semba Biosciences, Inc.

Before joining Semba Biosciences, Bob founded Novagen in 1989, where he served in various management and technical capacities before and after the company's sale to Merck in 1999.

Bob has a Ph.D. in oncology from the University of Wisconsin-Madison.